StemCells CEO To Address Investors Online At Stem Cells Forum Thursday, August 31

SUNNYVALE, Calif. -- (BW HealthWire) -- Aug. 30, 2000 -- StemCells Inc. (Nasdaq:STEM), announced today that Acting President and Chief Executive Officer George Dunbar will participate in a virtual forum on stem cell technology this Thursday.

The online forum will focus on The U.S. National Institutes of Health's revised guidelines allowing public funding for research using cells from human embryos, which were announced last week.

Steve Charest, from the May Davis Group, will provide an analyst perspective on how the issuance of the new guidelines will affect industrial and academic stem cell research.

The Forum begins at 8:00 a.m. (PDT) Thursday, August 31. It can be accessed by logging on to www.InformedInvestors.com and clicking on the Virtual StemCells Forum link. Questions can be typed in using the online question form in the browser window.

#########################

StemCells Inc., is a biotechnology company focused on the discovery, development and commercialization of stem cell-based therapies to treat diseases of the central nervous system, liver, and pancreas. The company's stem cell programs seek to repair or repopulate neural or other tissue that has been damaged or lost as a result of disease or injury.


CONTACT:	StemCells Inc.
	George Dunbar, Acting President and CEO
	408/731-8670
	or
	IR PR Strategies
	Media Contact:
	Anette Breindl or Allison Small
	858/860-0266
	or
	InformedInvestors.com
	Brian Finnigan or Steve Chanecka
	916/780-6100 or 800/992-4683